Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1345968 | Tetrahedron: Asymmetry | 2012 | 11 Pages |
A sugar allyltin derivative (with the d-gluco-configuration) was converted into d-xylo-dienoaldehyde and then into several bicyclic highly oxygenated compounds. The proposed methodology allows for a convenient synthesis of such derivatives containing heteroatoms other than oxygen. Molecular docking studies employing AutoDock 4.2 and AutoDock Vina were conducted in order to evaluate their activity as glycosidase inhibitors.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
(1R,2R,3S,4R,5R,6R,9S,10R)-1,2,3,4,6-Pentabenzyloxy-9-[(4′R)-2′,2′-dimethyl-1′,3′-dioxolane-4′-yl]bicyclo[4.4.0]dec-7,8-eneC50H54O7[α]D22=-11.2 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6R,9S,10R,4′R)
(1S,4S,5R,6S,7R,8R,9S,10R,11S)-5,6,7,8-Tetrabenzyloxy-11-acetyloxy-13-oxatricyclo[8.3.0.04,9]tridec-2,3-eneC42H44O7[α]D22=+171.2 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1S,4S,5R,6S,7R,8R,9S,10R,11S)
(1R,2R,3S,4R,5R,9S,10R)-1,2,3,4-Tetrabenzyloxy-9-acetyloxymethylbicyclo[4.4.0]dec-6,7-eneC39H42O5[α]D22=+103.7 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,9S,10R)
(1R,2R,3S,4R,5R,9S,10R)-1,2,3,4-Tetrabenzyloxy-9-(benzyloxymethylene)bicyclo [4.4.0]dec-6,7-eneC46H48O5[α]D22=+71.0 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,9S,10R)
(1R,2R,3S,4R,5R,6R,9S,10R)-1,2,3,4-Tetrabenzyloxy-6-acetyloxy-9-(benzyloxymethyl)]bicyclo[4.4.0]dec-7,8-eneC48H50O7[α]D22=-12.5 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6R,9S,10R)
(1R,2R,3S,4R,5R,6R,9S,10R)-[1,2,3,4-Tetrabenzyloxy-7-acetyloxy-9-(benzyloxymethylene)bicyclo[4.4.0]dec-5,6-eneC48H50O7[α]D22=-7.1 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6R,9S,10R)
(1R,2R,3S,4R,5R,6S,7R,8S,9S,10R)-1,2,3,4-Tetrabenzyloxy-6,7,8-triacetyloxy-9-benzyloxymethylbicyclo[4.4.0]decaneC52H56O11[α]D22=-34.5 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6S,7R,8S,9S,10R)
(1R,2R,3S,4R,7S,9S,10R)-1,2,3,4-Tetrabenzyloxy-9-benzyloxymethylbicyclo[4.4.0]-dec-5,6-en-7-yl 4-nitrobenzoateC53H51O9N[α]D22=+35.2 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,7S,9S,10R)
(1R,2R,3S,4R,7S,9S,10R)-1,2,3,4-Tetrabenzyloxy-9-[(4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl]bicyclo[4.4.0]-dec-5,6-en-7-yl 4-nitrobenzoateC50H51O10N[α]D22=+80.7 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,7S,9S,10R,4′R)
(1R,2R,3S,4R,5R,6S,7S,9S,10R)-1,2,3,4-Tetrabenzyloxy-6-acetyloxy-7-thiocyano-9-[(4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-ylo]bicyclo[4.4.0]decaneC46H51NO8S[α]D22=+16.6 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6S,7S,9S,10R,4′R)
(1R,2R,3S,4R,5R,6S,7S,9S,10R)-1,2,3,4-Tetrabenzyloxy-6-thiocyano-7-acetyloxy-9-[(4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl]bicyclo[4.4.0]decaneC46H51NO8S[α]D22=-1.4 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6S,7S,9S,10R,4′R)
(1R,2R,3S,4R,5R,6S,7S,9S,10R)-1,2,3,4-Tetrabenzyloxy-6-acetyloxy-7-diphenylphosphoryl-9-[(4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl]bicyclo[4.4.0]-decaneC57H61O9P[α]D22=-1.7 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6S,7S,9S,10R,4′R)
(1R,2R,3S,4R,5R,6S,7S,9S,10R)-1,2,3,4-Tetrabenzyloxy-6-diphenylphosphoryl-7-acetyloxy-9-[(4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl]bicyclo[4.4.0]-decaneC57H61O9P[α]D22=-1.4 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6S,7S,9S,10R,4′R)
(1R,2R,3S,4R,5R,6S,7S,9S,10R)-1,2,3,4-Tetrabenzyloxy-6-hydroxy-7-sulfanyl-9-[(4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-ylo]bicyclo[4.4.0]decaneC43H50O7S[α]D22=+20.5 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6S,7S,9S,10R,4′R)
(1R,2R,3S,4R,5R,6S,7S,9S,10R)-1,2,3,4-Tetrabenzyloxy-6-sulfanyl-7-hydroxy-9-[4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-ylo]bicyclo[4.4.0]decaneC43H50O7S[α]D29=+14.5 (c 1, CHCl3)Source of chirality: chiral poolAbsolute configuration: (1R,2R,3S,4R,5R,6S,7S,9S,10R,4′R)